Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

K Aronson

Showing results (1-10 of 633) with videos related to

Pageof 64
Sort By:
BMJ (Clinical Research Ed.)|June 13, 2022
When I use a word . . . . Counterfactual medical history: Milton's blindnessJeffrey K Aronson
BMJ (Clinical Research Ed.)|December 12, 2023
When I use a word . . . Medicines regulation-Patent medicinesJeffrey K Aronson
BMJ (Clinical Research Ed.)|December 12, 2023
When I use a word . . . Medicines regulation-chloroformJeffrey K Aronson
British Journal of Clinical Pharmacology|July 20, 2007
An agenda for research on adverse drug reactionsJ K Aronson
British Journal of Clinical Pharmacology|July 18, 2006
Risk perception in drug therapyJ K Aronson
BMJ (Clinical Research Ed.)|August 29, 2025
When I use a word . . . Academic sleuthsJeffrey K Aronson
Expert Review of Clinical Pharmacology|May 29, 2015
Toward standardized reporting of drug interactions: the READI checklist for anecdotal reportsJeffrey K Aronson
British Journal of Clinical Pharmacology|December 15, 2004
Citation classics in the British Journal of Clinical Pharmacology, 1974-2003J K Aronson
British Journal of Clinical Pharmacology|March 18, 2004
Drug interactions-information, education, and the British National FormularyJ K Aronson
Journal of Medical Screening|March 10, 2004
Live long and prosper: a mass strategy for treating the factors associated with ischaemic heart disease and strokeJ K Aronson
Pageof 64

Showing results (1-10 of 633) with videos related to

Sort By:
Pageof 64
BMJ (Clinical Research Ed.)|June 13, 2022
When I use a word . . . . Counterfactual medical history: Milton's blindnessJeffrey K Aronson
BMJ (Clinical Research Ed.)|December 12, 2023
When I use a word . . . Medicines regulation-Patent medicinesJeffrey K Aronson
BMJ (Clinical Research Ed.)|December 12, 2023
When I use a word . . . Medicines regulation-chloroformJeffrey K Aronson
British Journal of Clinical Pharmacology|July 20, 2007
An agenda for research on adverse drug reactionsJ K Aronson
British Journal of Clinical Pharmacology|July 18, 2006
Risk perception in drug therapyJ K Aronson
BMJ (Clinical Research Ed.)|August 29, 2025
When I use a word . . . Academic sleuthsJeffrey K Aronson
Expert Review of Clinical Pharmacology|May 29, 2015
Toward standardized reporting of drug interactions: the READI checklist for anecdotal reportsJeffrey K Aronson
British Journal of Clinical Pharmacology|December 15, 2004
Citation classics in the British Journal of Clinical Pharmacology, 1974-2003J K Aronson
British Journal of Clinical Pharmacology|March 18, 2004
Drug interactions-information, education, and the British National FormularyJ K Aronson
Journal of Medical Screening|March 10, 2004
Live long and prosper: a mass strategy for treating the factors associated with ischaemic heart disease and strokeJ K Aronson
Pageof 64